Company Active LTD

Company profile

Vision Technologies Ltd

GiveVision - Home page

GiveVision

CRN
09119352
Founded
2014
Age
11

Overview

Legal name
VISION TECHNOLOGIES LTD
Region
London
Registered address
86-90 PAUL STREET LONDON
PAUL STREET
LONDON
ENGLAND
EC2A 4NE
Insolvency history
No

Latest accounts

Financial period: 1 Aug 2023 to 31 Jul 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
0

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

20 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

06 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

07 Jul
2014

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2017
Funded years
2017, 2021, 2022, 2023
Age at first award
3 years

Projects

2023 Collaborative R&D Lead participant

AVIS - Accessibility for the Visually Impaired in Stadiums

1 Feb 2023 to 31 Jan 2024

Awarded
£200,738
Total cost £446,085

* 2 million people in the UK are visually impaired (VI), that's about 1 out of 30\. However, according to FA only 1 in 3000 stadium tickets are purchased by people with sight loss. * The disparity is unsurprising, considering that the only accessibility provision for the VI at stadiums is audio commentary narrated via a set of radio headphones. Since ther...

2022 Collaborative R&D Lead participant

SightScan - a wearable OCT-like monitoring for high risks AMD patients

1 Apr 2022 to 31 Mar 2023

Awarded
£50,000
Total cost £50,000

Globally, some 220 million people are affected by sight impediments. These conditions have a negative impact on users' well-being in terms of social inclusion, independence, ability to carry out activities of daily living, quality of life, and health and expose groups suffering them that include the elderly to even more vulnerability in their daily lives....

2022 Collaborative R&D Lead participant

Clinical & market study setup

1 Jan 2022 to 31 Mar 2022

Awarded
£20,405
Total cost £29,150

GiveVision has an innovative solution in the fields of ophthalmic telemonitoring in order to support patients undergoing wet Age-Related Macular Degeneration (wetAMD) therapy. Our solution has the potential to significantly enhance patient outcomes if supplied as a companion monitoring device to patients undergoing Anti-VEGF therapy (gold standard treatme...

2021 Collaborative R&D Lead participant

SightPlus Diagnostic (res)

1 Dec 2021 to 31 Jan 2022

Awarded
£91,750
Total cost £91,750

Globally, some 217 million people are affected by sight impediments. These conditions have a negative impact on sufferers' well-being in terms of social inclusion, independence, ability to carry out activities of daily living, quality of life, and health and expose groups suffering them that include the elderly to even more vulnerability in their daily liv...

2021 CR&D Bilateral Lead participant

SightPlus Diagnostic

1 Mar 2021 to 30 Nov 2022

Awarded
£208,565
Total cost £316,007

Globally, some 217 million people are affected by sight impediments. These conditions have a negative impact on sufferers' well-being in terms of social inclusion, independence, ability to carry out activities of daily living, quality of life, and health and expose groups suffering them that include the elderly to even more vulnerability in their daily liv...

2017 Collaborative R&D Lead participant

Proof of concept and technical evaluation of innovative, wearable Vision Enhancement device

1 Oct 2017 to 31 Mar 2019

Awarded
£285,171
Total cost £407,360

Visual impairments are a growing concern in society, with especially age contributing to an increasing number of people unable to see sufficiently in order to live independently. Visual impairments can make it difficult or impossible to perform simple daily activities such as reading, watching television or even see facial expressions in a conversation an...

Product types

Collaborative R&D CR&D Bilateral